Studies of variations of subcutaneously infused desferrioxamine and iron movements in thalassaemia children
暂无分享,去创建一个
[1] E. Chew,et al. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. , 1986, The New England journal of medicine.
[2] J. Ducobu,et al. OCULAR TOXICITY OF DESFERRIOXAMINE , 1985, The Lancet.
[3] F. Mandelli,et al. A study of the mechanisms and sites of action of desferrioxamine in thalassaemia major. , 1984, Acta haematologica.
[4] B. Modell,et al. The Clinical Approach to Thalassaemia , 1984 .
[5] C. Borgna-Pignatti,et al. VISUAL LOSS IN PATIENT ON HIGH-DOSE SUBCUTANEOUS DESFERRIOXAMINE , 1984, The Lancet.
[6] K. Ang,et al. DESFERRIOXAMINE, OCULAR TOXICITY, AND TRACE METALS , 1983, The Lancet.
[7] G. Arden,et al. OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINE , 1983, The Lancet.
[8] M. Pippard,et al. Ferrioxamine excretion in iron-loaded man. , 1982, Blood.
[9] R. Peto,et al. Survival and desferrioxamine in thalassaemia major. , 1982, British medical journal.
[10] G. Masera,et al. Haemoglobin levels and blood requirement in thalassaemia. , 1982, Archives of disease in childhood.
[11] K. Betke,et al. Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload , 1981, European Journal of Pediatrics.
[12] A. Cohen,et al. DECREASING IRON STORES DURING INTENSIVE CHELATION THERAPY * , 1980 .
[13] A. Jacobs,et al. Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects , 1979, British journal of haematology.
[14] D. Weatherall,et al. PREVENTION OF IRON LOADING IN TRANSFUSION-DEPENDENT THALASSÆMIA , 1978, The Lancet.
[15] J. Graziano,et al. Chelation therapy in beta-thalassemia major. I. Intravenous and subcutaneous deferoxamine. , 1978, The Journal of pediatrics.
[16] W. Anderson,et al. Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload , 1977 .
[17] P. Houzé,et al. Quantification of desferrioxamine in blood plasma by inductively coupled plasma atomic emission spectrometry. , 1987, Clinical chemistry.
[18] S. De Virgiliis,et al. Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients. , 1983, The American journal of pediatric hematology/oncology.
[19] S. De Virgiliis,et al. Auditory involvement in thalassemia major. , 1979, Acta haematologica.